Amendment to Annual Report — [x] Reg. S-K Item 405 — Form 10-K
Filing Table of Contents
Document/Exhibit Description Pages Size
1: 10-K405/A Cephalon, Inc. Form 10-K405/A Amendment No. 1 7 42K
2: EX-4.3(B) Form of Revenue Sharing Senior Secured Note 49 186K
7: EX-10.12 Toll Manufacturing and Packaging Agreement 30 99K
3: EX-10.5H Amendment No. 5 to License Agreement 3 16K
4: EX-10.5I Amendment No. 6 to License Agreement 3 15K
5: EX-10.5J Amendment No. 3 to Trademark Agreement 2 8K
6: EX-10.5K Amendment No. 4 to Trademark Agreement 2 10K
EX-10.5K — Amendment No. 4 to Trademark Agreement
EX-10.5K | 1st Page of 2 | TOC | ↑Top | Previous | Next | ↓Bottom | Just 1st |
---|
Exhibit 10.5(k)**
February 9, 1998
Genelco S.A.
8 Route de Beaumont
1701 Fribourg
Switzerland
Re: Amendment No. 4 to Trademark Agreement
--------------------------------------
Gentlemen:
This letter agreement shall serve as an amendment to the Trademark
Agreement dated January 20, 1993, as amended prior to the date hereof (the
"Trademark Agreement") between Cephalon, Inc. ("Cephalon") and Genelco S.A.
("Genelco"). All capitalized terms not otherwise defined herein shall be used as
defined in the Trademark Agreement.
1. The term "Territory," for all purposes under the Trademark Agreement is
hereby expanded to include the Republics of Italy and San Marino
(collectively, "Italy").
2. All trademark applications and registered trademarks related to Licensed
Products and/or the Compound, including the mark "Provigil", that are or
will be filed in the Territory are hereby licensed to Cephalon under the
Trademark Agreement.
3. For and in consideration of the expansion of the Territory to include Italy
under this Amendment No. 4 (and in addition to any compensation payable
under the Trademark Agreement with respect to other countries in the
Territory), Cephalon will pay to Genelco, pursuant to Article III(1) of the
Trademark Agreement, a royalty with respect to Net Sales of a Licensed
Product in Italy that will be calculated at the rate of [*] of such Net
Sales.
4. Each of Cephalon and Genelco hereby restates its respective representations
and warranties made in the Trademark Agreement, as amended pursuant to this
letter agreement.
5. Except as modified by this letter agreement, all provisions of the
Trademark Agreement are confirmed to be and shall remain in full force and
effect.
* THE CONFIDENTIAL MATERIAL CONTAINED HEREIN
HAS BEEN OMITTED AND HAS BEEN FILED
SEPARATELY WITH THE COMMISSION.
** Certain portions of this exhibit have been omitted based upon a request for
confidential treatment that has been filed with the Commission. The omitted
portions have been filed separately with the Commission.
Genelco S.A.
Amendment No. 4
February 9, 1998
Page 2
If the foregoing is acceptable, please indicate your agreement in the space
provided below.
CEPHALON, INC.
By: /s/ Frank Baldino
-------------------------------------
Frank Baldino, Jr., Ph.D.
President and Chief Executive Officer
Accepted and agreed to this
23/rd/ day of February, 1998.
GENELCO S.A.
By: /s/ [SIGNATURE ILLEGIBLE]
-------------------------------
Dates Referenced Herein and Documents Incorporated by Reference
↑Top
Filing Submission 0001036050-99-001155 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help —
Mon., Apr. 29, 6:27:54.1pm ET